No earnings within 2 weeks of this transaction.
| Insider | REED JOHN C |
|---|---|
| Title | EVP, Innovative Medicine, R&D |
| Transaction Date | Feb 17, 2026 |
| Expiration Date | Feb 15, 2035 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Employee Stock Options (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 15, 2026 |
| Shares Purchased | 29,927 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 59,854 |
| Derivative | Derivative |
| Accession Number | 0000200406-26-000039 |
| Document | View SEC Filing |